Suchergebnisse - "Vaduganathan, Muthiah"

PubPharm (57)

1

Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF : The DELIVER Trial

enthalten in: JACC. Heart failure | 2024

von Peikert, A. | Bart, B. | Vaduganathan, M. | +16

2

Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF

enthalten in: Journal of the American College of Cardiology | 2024

von Kondo, T. | Mogensen, U. | Talebi, A. | +15

3

Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin : A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER

enthalten in: Journal of cardiac failure | 2024

von Butt, J. | Jering, K. | DE Boer, R. | +20

4

Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction : An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials

enthalten in: Journal of the American Heart Association | 2024

von Bhatt, A. | Vaduganathan, M. | Claggett, B. | +13

5

Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction : A Post Hoc Analysis of the DELIVER Trial

enthalten in: JAMA cardiology | 2024

von Vardeny, O. | Desai, A. | Jhund, P. | +14

6

Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction : A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial

enthalten in: JAMA cardiology | 2024

von Mc Causland, F. | Claggett, B. | Vaduganathan, M. | +19

7

Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial

enthalten in: European journal of heart failure | 2023

von Bhatt, A. | Kosiborod, M. | Claggett, B. | +21

8

Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction : The DELIVER Trial

enthalten in: Circulation | 2023

von Ostrominski, J. | Vaduganathan, M. | Selvaraj, S. | +15

9

Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade : A Joint Analysis of the CREDENCE and DAPA-CKD Trials

enthalten in: Journal of the American Society of Nephrology : JASN | 2023

von Fletcher, R. | Jongs, N. | Chertow, G. | +13

10

Efficacy of Dapagliflozin According to Heart Rate : A Patient-Level Pooled Analysis of DAPA-HF and DELIVER

enthalten in: Circulation. Heart failure | 2023

von Kondo, T. | Butt, J. | Curtain, J. | +17

1
2
3
4
5
6
Nächster »
[6]